• Evaluation of Bevacizumab in Patients with Brain Radionecrosis After Radiation Treatment for Brain Metastases

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • Study on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Portugal Spain

  • Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Ireland Spain

  • Study on Reducing JAK Inhibitor Doses in Patients with Low Disease Activity in Rheumatoid Arthritis Using Tofacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Long-term Safety Study of Exagamglogene Autotemcel for Patients with Sickle Cell Disease or Transfusion-Dependent Thalassemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Italy

  • Study to Compare Non-Radioactive Methods for Measuring Kidney Function in Patients with Chronic Kidney Disease Using Sodium Iotalamate, Sodium Iodohippurate, and Iohexol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +4

  • Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium France Germany Greece Hungary +8

  • Study of Talazoparib and Enzalutamide combination treatment for patients with metastatic prostate cancer who previously received Abiraterone

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France Spain

powered by